• Exchange: Continuous
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Natraceutical SA

+ Add to Watchlist

NTC:SM

0.2340 EUR 0.0050 2.18%

As of 11:38:00 ET on 08/29/2014.

Snapshot for Natraceutical SA (NTC)

Open: 0.2280 Day's Range: 0.2280 - 0.2410 Volume: 390,803
Previous Close: 0.2290 52wk Range: 0.2100 - 0.3500 1-Yr Rtn: -4.10%

Stock Chart for NTC

No chart data available.
  • NTC:SM 0.2340
  • 1D
  • 1M
  • 1Y
0.2290
Interactive NTC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NTC

Current P/E Ratio (ttm) 126.2817
Estimated P/E(12/2014) 33.4286
Relative P/E vs. IBEX 5.9539
Earnings Per Share (EUR) (ttm) 0.0019
Est. EPS (EUR) (12/2014) 0.0070
Est. PEG Ratio -
Market Cap (M EUR) 76.92
Shares Outstanding (M) 328.71
30 Day Average Volume 252,318
Price/Book (mrq) 1.0027
Price/Sale (ttm) 2.5035
Dividend Indicated Gross Yield -%
Cash Dividend (EUR) 0.0292
Dividend Ex-Date 06/06/2013
5 Year Dividend Growth -
Next Earnings Announcement 08/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NTC

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for NTC

Natraceutical SA manufactures natural extracts for the food and cosmetics markets. The Company produces caffeine primarily for soft drinks and pharmaceuticals manufacturers, polyphenols, flavonoids, biotechnological extracts, and vegetable oil extracts. Natraceutical develops functional foods, and conducts research on molecules useful in human health products.

Francois GaydierChief Executive OfficerMaria Jose Busutil SantosSecretary
More Company Profile & Key Executives for NTC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil